Cargando…

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel

Bispecific antibodies (BsAbs) are emerging as an important novel class of immunotherapeutic agents for the treatment of multiple myeloma (MM), and are set to be more widely used in clinical practice. However, this new class of therapies is associated with a distinct adverse event (AE) profile that i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raje, Noopur, Anderson, Kenneth, Einsele, Hermann, Efebera, Yvonne, Gay, Francesca, Hammond, Sarah P., Lesokhin, Alexander M., Lonial, Sagar, Ludwig, Heinz, Moreau, Philippe, Patel, Krina, Ramasamy, Karthik, Mateos, Maria-Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394080/ https://www.ncbi.nlm.nih.gov/pubmed/37528088 http://dx.doi.org/10.1038/s41408-023-00879-7

Ejemplares similares

When an embarrassment of riches isn’t enough
por: Patel, Krina, et al.
Publicado: (2022)

International Expert Panel Consensus on Fat Grafting of the Breast
por: Nava, Maurizio B., et al.
Publicado: (2019)

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma
por: Dimopoulos, M A, et al.
Publicado: (2014)

Prophylaxis for preventing venous thromboembolism in knee arthroscopy and soft tissue reconstruction: consensus statements from an international panel of experts
por: Easwaran, Raju, et al.
Publicado: (2022)

Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial
por: Bahlis, Nizar J., et al.
Publicado: (2023)

Hyperkalemia management in the emergency department: An expert panel consensus
por: Rafique, Zubaid, et al.
Publicado: (2021)

P880: EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A SUBGROUP ANALYSIS FROM MAGNETISMM-3
por: Leleu, Xavier, et al.
Publicado: (2023)

Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
por: Zhou, Xiang, et al.
Publicado: (2020)

Critical Resources for Hospital Surge Capacity: An Expert Consensus Panel
por: Bayram, Jamil D., et al.
Publicado: (2013)

S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3
por: Mohty, Mohamad, et al.
Publicado: (2023)

Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
por: Raje, Noopur, et al.
Publicado: (2023)

Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
por: Raje, Noopur, et al.
Publicado: (2023)

P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
por: Bahlis, Nizar J, et al.
Publicado: (2023)

The Future of Adhesion Prophylaxis Trials in Abdominal Surgery: An Expert Global Consensus †
por: De Wilde, Rudy Leon, et al.
Publicado: (2022)

ClinGen’s RASopathy Expert Panel Consensus Methods for Variant Interpretation
por: Gelb, Bruce D., et al.
Publicado: (2018)

Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children
por: Galindo-Zavala, Rocío, et al.
Publicado: (2020)

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
por: Lejeune, Margaux, et al.
Publicado: (2020)

Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma
por: Richardson, Paul G., et al.
Publicado: (2023)

Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel
por: De Stefano, Valerio, et al.
Publicado: (2022)

Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India)
por: Rajagopalan, Murlidhar, et al.
Publicado: (2018)

The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensus
por: Muenzer, Joseph, et al.
Publicado: (2011)

Expert Panel Workshop Consensus Statement on the Role of the Environment in the Development of Autoimmune Disease
por: Parks, Christine G., et al.
Publicado: (2014)

Recommendations for effective documentation in regional anesthesia: an expert panel Delphi consensus project
por: Ahmed, Hassan M, et al.
Publicado: (2022)

EXPERT CONSENSUS PANEL RECOMMENDATIONS FOR MEDICAL AND MENTAL HEALTH CARE IN ASSISTED LIVING
por: Zimmerman, Sheryl, et al.
Publicado: (2022)

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
por: Lesokhin, Alexander M., et al.
Publicado: (2023)

Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses
por: Xu, Xu Steven, et al.
Publicado: (2020)

Systemic Management of Psoriasis Patients in Indian Scenario: An Expert Consensus
por: Rajagopalan, Murlidhar, et al.
Publicado: (2021)

Informed consent in clinical research: Consensus recommendations for reform identified by an expert interview panel
por: Lorell, Beverly H, et al.
Publicado: (2015)

Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection
por: Qi, Man-Li, et al.
Publicado: (2017)

Radiofrequency ablation for hepatic hemangiomas: A consensus from a Chinese panel of experts
por: Gao, Jun, et al.
Publicado: (2017)

Expert panel consensus statement on the applications and precaution strategies of bronchoscopy in patients with COVID-19
por: Yang, Huizhen, et al.
Publicado: (2020)

Consensus standards for the process of cancer care: a modified expert panel method applied to head and neck cancer. South and West Expert Tumour Panel for Head and Neck Cancer.
por: Birchall, M. A.
Publicado: (1998)

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
por: Yee, Andrew J, et al.
Publicado: (2012)

Panobinostat and Multiple Myeloma in 2018
por: Yee, Andrew J., et al.
Publicado: (2018)

How We Approach Smoldering Multiple Myeloma
por: Raje, Noopur, et al.
Publicado: (2020)

Smoldering multiple myeloma current treatment algorithms
por: Rajkumar, S. Vincent, et al.
Publicado: (2022)

International Expert Panel Consensus Guidelines for Structure and Delivery of Qigong Exercise for Cancer Care Programming
por: Klein, Penelope, et al.
Publicado: (2017)

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel
por: Wu, Yi-Long, et al.
Publicado: (2017)

793. Expert Panel Consensus Ranking of Comorbid Conditions Causally Related to Clostridioides difficile Infection
por: Goodman, Katherine E, et al.
Publicado: (2020)

Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
por: Buzzetti, Raffaella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dhifeovibfcbnm7dca9qb96aa7